The center, which will operate as part of the hospital’s current cancer center, will initially focus on drugs specific to the genetic makeup of tumors, including breast cancers, lung cancers and leukemias. Physicians and scientists also plan to test a new generation of targeted drugs for cancer care.
The hospital will use the grant to renovate the seventh floor of its Yawkey Center for Outpatient Care, purchase medical equipment, recruit new employees and offset the cost of its future clinical trials.
Hospital officials hope to raise an additional $10 million over the next two years to support the new center.
Related Articles on Hospital Cancer Center Construction:
Pennsylvania’s Mercy Suburban Hospital Breaks Ground on $8M Cancer Center
Michigan’s $5M Monroe Cancer Center Opens
Pennsylvania’s Lancaster General Health to Begin $44M Cancer Center Construction
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
